Abstract
Five hundred patients undergoing cataract surgery were prospectively examined, and 46 Caucasian patients were found to have strictly idiopathic cataracts severe enough to warrant surgery on or before age 55. In a masked fashion we determined the activity of galactokinase (GK) and galactose-1-phosphate uridyl transferase (GPUT) in these patients as well as on 53 age matched controls. With respect to GK no cataract patient had an enzyme level of less than 2 standard deviations below the control mean. However, 3 of 45 (6.7%) patients in the cataract group had a GPUT level less than 2 standard deviations below the mean for controls, and were presumably heterozygotes for this enzyme. In comparison with the expected population rate of 0.8% this is highly significant (p = 0.006). Abnormalities in galactose pathway enzymes may therefore predispose to development of presenile cataracts. In affected people there is a possibility of treating these patients clinically by dietary restriction of dairy products or by using aldose reductase inhibitors to prevent or reverse cataract formation.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beutler E., West C., Blume K. G. The removal of leukocytes and platelets from whole blood. J Lab Clin Med. 1976 Aug;88(2):328–333. [PubMed] [Google Scholar]
- Cogan D. G., Kinoshita J. H., Kador P. F., Robison G., Datilis M. B., Cobo L. M., Kupfer C. NIH conference. Aldose reductase and complications of diabetes. Ann Intern Med. 1984 Jul;101(1):82–91. doi: 10.7326/0003-4819-101-1-82. [DOI] [PubMed] [Google Scholar]
- Datiles M., Fukui H., Kuwabara T., Kinoshita J. H. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. Invest Ophthalmol Vis Sci. 1982 Feb;22(2):174–179. [PubMed] [Google Scholar]
- Elman M. J., Miller M. T., Matalon R. Galactokinase activity in patients with idiopathic cataracts. Ophthalmology. 1986 Feb;93(2):210–215. doi: 10.1016/s0161-6420(86)33761-8. [DOI] [PubMed] [Google Scholar]
- Hu T. S., Datiles M., Kinoshita J. H. Reversal of galactose cataract with Sorbinil in rats. Invest Ophthalmol Vis Sci. 1983 May;24(5):640–644. [PubMed] [Google Scholar]
- Kinoshita J. H. Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol. 1974 Oct;13(10):713–724. [PubMed] [Google Scholar]
- Levy H. L., Hammersen G. Newborn screening for galactosemia and other galactose metabolic defects. J Pediatr. 1978 Jun;92(6):871–877. doi: 10.1016/s0022-3476(78)80351-5. [DOI] [PubMed] [Google Scholar]
- Levy N. S., Krill A. E., Beutler E. Galactokinase deficiency and cataracts. Am J Ophthalmol. 1972 Jul;74(1):41–48. doi: 10.1016/0002-9394(72)91123-3. [DOI] [PubMed] [Google Scholar]
- Monteleone J. A., Beutler E., Monteleone P. L., Utz C. L., Casey E. C. Cataracts, galactosuria and hypergalactosemia due to galactokinase deficiency in a child. Studies of a kindred. Am J Med. 1971 Mar;50(3):403–407. doi: 10.1016/0002-9343(71)90230-0. [DOI] [PubMed] [Google Scholar]
- Skalka H. W., Prchal J. T. Presenile cataract formation and decreased activity of galactosemic enzymes. Arch Ophthalmol. 1980 Feb;98(2):269–273. doi: 10.1001/archopht.1980.01020030265003. [DOI] [PubMed] [Google Scholar]
- Stambolian D., Scarpino-Myers V., Eagle R. C., Jr, Hodes B., Harris H. Cataracts in patients heterozygous for galactokinase deficiency. Invest Ophthalmol Vis Sci. 1986 Mar;27(3):429–433. [PubMed] [Google Scholar]
- Tedesco T. A., Bonow R., Miller K., Mellman W. J. Galactokinase: evidence for a new racial polymorphism. Science. 1972 Oct 13;178(4057):176–178. doi: 10.1126/science.178.4057.176. [DOI] [PubMed] [Google Scholar]